Based on proprietary microdroplet precision control technology, integrating multimodal biosensing and real-time feedback systems to create a leading intelligent cell printing platform.

By deeply automating traditional experimental processes, it helps customers achieve greater productivity in fields such as 3D cell culture, organoid models, and early drug research, overcoming the limitations of manual operations in traditional 3D culture, improving the success rate and consistency of experimental data in humanized or more complex model construction, and providing complete solutions for standardized platforms from the laboratory to industrial levels, supporting the vigorous development of organoids and regenerative medicine industries.

Online consultation